Eurofins Scientific (France) Performance
| ERF Stock | EUR 52.22 2.79 5.64% |
On a scale of 0 to 100, Eurofins Scientific holds a performance score of 10. The firm shows a Beta (market volatility) of 0.0936, which means not very significant fluctuations relative to the market. As returns on the market increase, Eurofins Scientific's returns are expected to increase less than the market. However, during the bear market, the loss of holding Eurofins Scientific is expected to be smaller as well. Please check Eurofins Scientific's semi variance, rate of daily change, and the relationship between the value at risk and kurtosis , to make a quick decision on whether Eurofins Scientific's price patterns will revert.
Risk-Adjusted Performance
10 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Eurofins Scientific SE are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak technical and fundamental indicators, Eurofins Scientific sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 910.5 M | |
| Total Cashflows From Investing Activities | -1 B |
Eurofins |
Eurofins Scientific Relative Risk vs. Return Landscape
If you would invest 4,593 in Eurofins Scientific SE on November 2, 2024 and sell it today you would earn a total of 629.00 from holding Eurofins Scientific SE or generate 13.69% return on investment over 90 days. Eurofins Scientific SE is generating 0.2242% of daily returns assuming 1.6573% volatility of returns over the 90 days investment horizon. Simply put, 14% of all stocks have less volatile historical return distribution than Eurofins Scientific, and 96% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Eurofins Scientific Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Eurofins Scientific's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Eurofins Scientific SE, and traders can use it to determine the average amount a Eurofins Scientific's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1353
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ERF | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.66 actual daily | 14 86% of assets are more volatile |
Expected Return
| 0.22 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.14 actual daily | 10 90% of assets perform better |
Based on monthly moving average Eurofins Scientific is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Eurofins Scientific by adding it to a well-diversified portfolio.
Eurofins Scientific Fundamentals Growth
Eurofins Stock prices reflect investors' perceptions of the future prospects and financial health of Eurofins Scientific, and Eurofins Scientific fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Eurofins Stock performance.
| Return On Equity | 0.15 | |||
| Return On Asset | 0.075 | |||
| Current Valuation | 15.18 B | |||
| Shares Outstanding | 192.56 M | |||
| Price To Earning | 41.19 X | |||
| Price To Book | 2.67 X | |||
| Price To Sales | 1.83 X | |||
| Revenue | 6.72 B | |||
| EBITDA | 1.6 B | |||
| Cash And Equivalents | 507.98 M | |||
| Cash Per Share | 28.62 X | |||
| Total Debt | 2.08 B | |||
| Debt To Equity | 115.90 % | |||
| Book Value Per Share | 24.42 X | |||
| Cash Flow From Operations | 1.51 B | |||
| Earnings Per Share | 2.97 X | |||
| Total Asset | 9.33 B | |||
| Retained Earnings | 159 M | |||
| Current Asset | 1.43 B | |||
| Current Liabilities | 775 M | |||
About Eurofins Scientific Performance
By analyzing Eurofins Scientific's fundamental ratios, stakeholders can gain valuable insights into Eurofins Scientific's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Eurofins Scientific has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Eurofins Scientific has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Eurofins Scientific SE, through its subsidiaries, provides various analytical testing services worldwide. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg. EUROFINS SCIENT operates under Diagnostics Research classification in France and is traded on Paris Stock Exchange. It employs 43819 people.Things to note about Eurofins Scientific performance evaluation
Checking the ongoing alerts about Eurofins Scientific for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Eurofins Scientific help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Eurofins Scientific has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| About 33.0% of the company shares are held by company insiders |
- Analyzing Eurofins Scientific's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Eurofins Scientific's stock is overvalued or undervalued compared to its peers.
- Examining Eurofins Scientific's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Eurofins Scientific's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Eurofins Scientific's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Eurofins Scientific's stock. These opinions can provide insight into Eurofins Scientific's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Eurofins Stock analysis
When running Eurofins Scientific's price analysis, check to measure Eurofins Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eurofins Scientific is operating at the current time. Most of Eurofins Scientific's value examination focuses on studying past and present price action to predict the probability of Eurofins Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eurofins Scientific's price. Additionally, you may evaluate how the addition of Eurofins Scientific to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |